AKT1 and hepatocellular carcinoma: It happens to be a key event to activate PI3-K/AKT signaling pathway and induce cisplatin resistance subsequently.[37], [38] Based on such information, we hypothesized that overexpression of Pyk2 may play a crucial part in cisplatin resistance in HCC.